Sampling of Thoracic Lymph Nodes and Lung Lesions: Trends in Procedural Utilization
Respiration · 2023
DOI: 10.1159/000530741 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiration, 2023. Verfasst von Momen M Wahidi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumothorax. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
Advances in bronchoscopy have impacted the practice patterns in the sampling of thoracic lymph nodes and lung lesions.
Objectives
The aim of the study was to study the trends in utilization of mediastinoscopy, transthoracic needle aspiration (TTNA), and bronchoscopic transbronchial sampling.
Methods
We conducted an analysis of patient claims for sampling of thoracic lymph nodes and lung lesions in the Medicare population and a sample of the commercial population between 2016 and 2020. We used Current Procedural Terminology codes to identify mediastinoscopy, TTNA, and bronchoscopic transbronchial sampling. Post-procedural pneumothorax rates were assessed by procedure type including subset analyses for patients with chronic obstructive pulmonary disease (COPD).
Results
Between 2016 and 2020, utilization of mediastinoscopy has decreased in both the Medicare and commercial populations (−47.3% and −65.4%, respectively), while linear endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) has increased only in the Medicare population (+28.2%). Percutaneous lung biopsy claims dropped by −17.0% in the Medicare and −41.22% in the commercial population. The use of bronchoscopic TBNA and forceps biopsy declined in both populations, but the reliance on a combination of guided technology (radial EBUS-guided and navigation) grew in the Medicare and commercial populations (+76.3% and +25%). Rates of post-procedural pneumothorax were significantly higher following percutaneous biopsy compared to bronchoscopic transbronchial biopsy.
Conclusions
Linear EBUS-guided sampling has surpassed mediastinoscopy as the technique for sampling thoracic lymph nodes. Transbronchial lung sampling is increasingly being performed with guidance technology. This trend is aligned with favorable rates of post-procedure pneumothorax for transbronchial biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Boston Scientific, Marlborough, Massachusetts, USA.
Zitieren
APA
Wahidi, M. M., Lee, S., Cramer, G. R., & Cangelosi, M. J. (2023). Sampling of Thoracic Lymph Nodes and Lung Lesions: Trends in Procedural Utilization. Respiration. https://doi.org/10.1159/000530741
Vancouver
Wahidi MM, Lee S, Cramer GR, Cangelosi MJ. Sampling of Thoracic Lymph Nodes and Lung Lesions: Trends in Procedural Utilization. Respiration. 2023. doi:10.1159/000530741
BibTeX
@article{Wahidi2023,
author = {Wahidi, Momen M and Lee, Sonia and Cramer, Geri R and Cangelosi, Michael J},
title = {Sampling of Thoracic Lymph Nodes and Lung Lesions: Trends in Procedural Utilization},
journal = {Respiration},
year = {2023},
doi = {10.1159/000530741}
}
EUVIMED